Get the Flash Player to see this rotator.

   The 2014 Oncology Days, organised in conjunction with the 2014 Annual General Assembly, contribute to confirm the role of the OECI to reduce fragmentation, to give the possibility to all European cancer patients to receive the best cures and to evaluate the costs-benefit linked with the application of new therapeutic approaches.
   In 2012, 3.45 million people were diagnosed with cancer and 1.75 million died of cancer. With an aging population, the burden that cancer imposes to our societies will increase. Cancer has replaced cardiovascular diseases as the leading cause of death in 28 of 53 European nations. Personalised medicine has the potential to transform the way healthcare is delivered by tailoring solutions to the individual patient and gaining in efficiency and efficacy. However, budget pressure and lack of professional skills in molecular diagnosis, are preventing patients and health systems from gaining access to some of these new approaches.     The Governments across Europe must be invited to adapt their health systems, otherwise disparities in cancer care and survival rate will increase as well as their burden on society.
The fragmentation in cancer treatment must be reduced and high quality clinical cancer care should be concentrated within hospital settings with verified clinical skills and internal organisation. On a European scale this is reflected in the growing interest in Accreditation and Designation for comprehensive cancer centers, sometimes in alignment with the accreditation systems already adopted at national level. As oncology represents 25-30% of most hospitals budget, it is a very good example of the restructuring of the hospital care landscape that is taking place in many western countries and can be posed as a challenge
to those countries that are now in a development stage of their healthcare systems. We acknowledge that Cancer is one of the best examples in which promising concepts of patient oriented organization, advanced flow methods and safe handover approaches across care settings need to be developed. A strong organisation of cancer institutes at a European level, such as the OECI, contributes to the diffusion of knowledge on the quality of cancer care and translational research, and can play a role in supporting progress in less developed countries.
   On February 18th, the OECI and the ECPC launched a debate at the European Parliament to underline the need that cancer professionals, patients and health authorities work together to find practical solutions giving adequate answers to the requests of the citizens who represent the centeredness of our efforts. The European Union has enforced the Directive 2011/24/EU, which improves patients’ rights and possibilities in cross-border healthcare. The Directive provides guidelines for accessing safe and high-quality cross-border healthcare, promotes cooperation between healthcare providers within the EU and foresees the development of European reference networks helpful to improve diagnostics and accessibility of costeffective healthcare among patients. The OECI is ready to contribute to the compliance with this Directive in the field of oncology.
   The decision to settle the Oncology Days 2014 in Cluj clearly reflects the awareness that the OECI has to improve the development of politics and programs involving more our Eastern colleagues. We would like to thank the Oncology Institute “Prof. Dr. I. Chiricuta” for hosting the event and for all the commitments given to support the organisation of the molecular pathology training activities, also in the past. In Cluj, I formally end my Presidency and, for the first time in its history, the OECI elected a woman to cover the position. On September 1st, 2014 it will be a great honor for me to leave the floor to Dr. Dominique De Valeriola, an example of a scientist and manager who will guarantees continuity to my work giving a greater commitment to the OECI to promote the patient-centeredness. I wish to Dominique all the best for her mandate.

Wim H. van Harten
OECI President
 

          It is our great honor to welcome you in Cluj-Napoca at the OECI 2014 Oncology Days.
        We are privileged to have you all here in one of the most beautiful cities of Transylvania, in
the heart of Romania.
        We are devoted to make the OECI 2014 Oncology Days an unforgettable experience, as
the Oncology Institute ”Prof.dr. Ion Chiricuta” Cluj-Napoca this year is celebrating its 85th
anniversary, a special milestone.
        There are a lot of issues regarding early prevention, precise diagnosis and personalised
treatment schemes in cancer. Together we can do more for people now facing this terrible
disease, as our primary goal should be to give them hope and life.
        The strategic approach of European oncology, in terms of clinical care and research for the
benefit of the patient, is a great challenge and, therefore, a comprehensive collaboration
between all OECI members becomes indispensable. Communication leads to progress, so
meeting to discuss cancer issues is consequently useful and enhancive.
       We truly believe that the OECI 2014 Oncology Days will fulfill their objectives and we assure
you of all our hospitality.

 

Assoc. Prof. Patriciu Achimas-Cadriu
Director
The Oncology Institute ”Prof.dr. Ion Chiricuta”
Cluj-Napoca, Romania
 

 

Programul poate fi accesat aici.

În paralel cu lucrările Zilelor IOCN 2014, Institutul va fi şi gazda unui eveniment internaţional de anvergură organizat în premieră în România - OECI (Organization of European Cancer Institutes) Oncology Days & General Assembly. Concret, manifestarea va avea loc în perioada 12 – 13 iunie 2014 şi reuneşte reprezentanţi din 70 de centre şi institute de cancer din Europa.

 

Toţi participanţii la manifestare vor primi la sfârşitul evenimentului un certificat de participare cu menţiunea orelor de educaţie medicală continuă (EMC) cu care a fost creditat evenimentul de către Colegiul Medicilor din Romania.